Skip to main content

Osteopenia clinical trials at UC Health
1 research study open to eligible people

  • Experimental medicine LLP2A-Alendronate for treatment of bone loss

    “The study to determine if the experimental medicine is safe”

    open to eligible people ages 20-75

    A Phase 1 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of the Safety and Tolerability of Intravenous LLP2A-Alendronate in Adult Men and Women with Osteopenia Secondary to Corticosteroids.

    at UC Davis

Last updated: